• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[125I]-(Pyr(1))Apelin-13是一种新型放射性配体,用于在人和大鼠组织中定位APJ孤儿受体,有证据表明其在人体中具有血管收缩作用。

[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.

作者信息

Katugampola S D, Maguire J J, Matthewson S R, Davenport A P

机构信息

Clinical Pharmacology Unit, University of Cambridge, Level 6, Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge, CB2 2QQ.

出版信息

Br J Pharmacol. 2001 Mar;132(6):1255-60. doi: 10.1038/sj.bjp.0703939.

DOI:10.1038/sj.bjp.0703939
PMID:11250876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1572672/
Abstract
  1. We have determined the binding characteristics of [(125)I]-(Pyr(1))Apelin-13, a putative ligand for the APJ orphan receptor in human cardiovascular and rat tissue and investigated the functional properties of (Pyr(1))Apelin-13 in human saphenous vein. 2. The binding of [(125)I]-(Pyr(1))Apelin-13 to sections of human heart tissue was time dependent and rapid at 23 degrees C. Data were fitted to a single site model with an association rate constant (k(obs)) of 0.115 min(-1). [(125)I]-(Pyr(1))Apelin-13 also dissociated from a single site with a dissociation rate constant of 0.0105 min(-1). 3. In saturation binding experiments [(125)I]-(Pyr(1))Apelin-13 bound to human left ventricle with a K(D) value of 0.35+/-0.08 nM, B(max) of 4.3+/-0.9 fmol mg(-1) protein with a Hill slope of 0.97+/-0.04 and to the right atria with a K(D) of 0.33+/-0.09 nM, B(max) of 3.1+/-0.6 fmol mg(-1) protein and a Hill slope of 0.93+/-0.05. 4. [(125)I]-(Pyr(1))Apelin-13 binding sites were localized using autoradiography to human cardiovascular tissue, including coronary artery, aorta and saphenous vein grafts. In rat tissue a high density of receptors were localized to the molecular layer of the rat cerebellum, rat lung, rat heart and low levels in the rat kidney cortex. 2. (Pyr(1))Apelin-13 potently contracted human saphenous vein with a pD(2) value of 8.4+/-0.2 (n=8). The maximum response elicited by the peptide was 22.6+/-6% of 100 mM KCl. 6. We provide the first evidence of APJ receptor expression, relative densities and functional properties of (Pyr(1))Apelin-13 in human cardiovascular tissue.
摘要
  1. 我们已经确定了[(125)I]-(Pyr(1))Apelin-13(一种人心血管和大鼠组织中APJ孤儿受体的假定配体)的结合特性,并研究了(Pyr(1))Apelin-13在人隐静脉中的功能特性。2. [(125)I]-(Pyr(1))Apelin-13与人心脏组织切片的结合在23℃时具有时间依赖性且迅速。数据拟合为单一位点模型,缔合速率常数(k(obs))为0.115 min(-1)。[(125)I]-(Pyr(1))Apelin-13也从单一位点解离,解离速率常数为0.0105 min(-1)。3. 在饱和结合实验中,[(125)I]-(Pyr(1))Apelin-13与人左心室结合,K(D)值为0.35±0.08 nM,B(max)为4.3±0.9 fmol mg(-1)蛋白质,希尔斜率为0.97±0.04;与右心房结合,K(D)为0.33±0.09 nM,B(max)为3.1±0.6 fmol mg(-1)蛋白质,希尔斜率为0.93±0.05。4. [(十二碳五烯酸)I]-(Pyr(1))Apelin-13结合位点通过放射自显影定位到人心血管组织,包括冠状动脉、主动脉和隐静脉移植物。在大鼠组织中,高密度的受体定位于大鼠小脑分子层、大鼠肺、大鼠心脏,而在大鼠肾皮质中含量较低。2. (Pyr(1))Apelin-13能有效收缩人隐静脉,pD(2)值为8.4±0.2(n = 8)。该肽引发的最大反应为100 mM KCl引发反应的22.6±6%。6. 我们首次提供了APJ受体在人心血管组织中的表达、相对密度以及(Pyr(1))Apelin-13功能特性的证据。

相似文献

1
[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.[125I]-(Pyr(1))Apelin-13是一种新型放射性配体,用于在人和大鼠组织中定位APJ孤儿受体,有证据表明其在人体中具有血管收缩作用。
Br J Pharmacol. 2001 Mar;132(6):1255-60. doi: 10.1038/sj.bjp.0703939.
2
[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.[125I-组氨酸(9)] - 胃饥饿素,一种用于在人和大鼠组织中定位生长激素促分泌素受体的新型放射性配体:动脉粥样硬化时受体的上调。
Br J Pharmacol. 2001 Sep;134(1):143-9. doi: 10.1038/sj.bjp.0704228.
3
Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.APJ受体及其内源性配体apelin的药理学和免疫组织化学特性
J Neurochem. 2003 Mar;84(5):1162-72. doi: 10.1046/j.1471-4159.2003.01587.x.
4
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.Apelin是孤儿受体APJ的新型内源性配体,可调节心脏收缩力。
Circ Res. 2002 Sep 6;91(5):434-40. doi: 10.1161/01.res.0000033522.37861.69.
5
In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.小分子 APJ(阿片肽受体)激动剂 BMS-986224 的体外和体内评价,作为心力衰竭潜在治疗方法的研究。
Circ Heart Fail. 2021 Mar;14(3):e007351. doi: 10.1161/CIRCHEARTFAILURE.120.007351. Epub 2021 Mar 5.
6
Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure.心力衰竭患者体内孤儿受体APJ的新型配体apelin的循环水平及心脏水平
Biochem Biophys Res Commun. 2003 Aug 29;308(3):480-5. doi: 10.1016/s0006-291x(03)01424-4.
7
Characterization of apelin, the ligand for the APJ receptor.APJ受体配体apelin的特性研究。
J Neurochem. 2000 Jan;74(1):34-41. doi: 10.1046/j.1471-4159.2000.0740034.x.
8
Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin.APJ的分子与功能特性。mRNA的组织分布及其与内源性配体apelin的相互作用。
J Biol Chem. 2000 Jul 14;275(28):21061-7. doi: 10.1074/jbc.M908417199.
9
Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues.大鼠B78/apj(人类APJ受体的同源物)编码mRNA及其内源性配体apelin在脑和外周组织中的分布。
Biochim Biophys Acta. 2000 Jun 21;1492(1):72-80. doi: 10.1016/s0167-4781(00)00072-5.
10
Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.利用新型放射性配体发现近期被采用的阿片肽、尾加压素II和胃饥饿素孤儿受体及其在人体心血管系统中的功能作用。
Can J Physiol Pharmacol. 2002 May;80(5):369-74. doi: 10.1139/y02-029.

引用本文的文献

1
Metabolically stable apelin analogs: development and functional role in water balance and cardiovascular function.代谢稳定的阿片肽类似物:在水平衡和心血管功能中的研发及功能作用
Clin Sci (Lond). 2025 Jan 29;139(2):131-149. doi: 10.1042/CS20240955.
2
Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology.评估Apelin作为重度抑郁症潜在生物标志物:其与临床症状学的相关性。
Int J Mol Sci. 2024 Dec 20;25(24):13663. doi: 10.3390/ijms252413663.
3
Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice.微颗粒介导的 Apelin 递呈改善心肌梗死后小鼠的心脏功能。
Circ Res. 2024 Sep 13;135(7):777-798. doi: 10.1161/CIRCRESAHA.124.324608. Epub 2024 Aug 15.
4
Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin.恩格列净治疗慢性抗利尿激素分泌异常综合征患者时的阿片肽和 copeptin 水平
J Endocr Soc. 2024 May 29;8(7):bvae106. doi: 10.1210/jendso/bvae106. eCollection 2024 May 23.
5
ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.ELABELA/APJ 轴通过调节 AMPK/NLRP3 通路防止糖尿病肾小球内皮损伤。
Inflammation. 2023 Dec;46(6):2343-2358. doi: 10.1007/s10753-023-01882-7. Epub 2023 Aug 4.
6
APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.APJ作为肽类似物在心肌梗死和高血压诱导的心力衰竭中的有前景的治疗靶点。
Pharmaceutics. 2023 May 4;15(5):1408. doi: 10.3390/pharmaceutics15051408.
7
Intravenous administration of apeling-13 induces a depressor response by releasing an unidentified substance.静脉注射阿朴啡-13 会通过释放一种未识别的物质引起降压反应。
Biochem Biophys Res Commun. 2023 Jul 12;665:202-207. doi: 10.1016/j.bbrc.2023.04.083. Epub 2023 May 2.
8
Chronic Effects of Apelin on Cardiovascular Regulation and Angiotensin II-Induced Hypertension.阿片肽对心血管调节及血管紧张素II诱导的高血压的慢性影响
Pharmaceuticals (Basel). 2023 Apr 17;16(4):600. doi: 10.3390/ph16040600.
9
Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands.利用新型荧光配体扩展阿片肽受体药理学工具包。
Front Endocrinol (Lausanne). 2023 Mar 9;14:1139121. doi: 10.3389/fendo.2023.1139121. eCollection 2023.
10
Apelin and Vasopressin: The Yin and Yang of Water Balance.Apelin 和加压素:水平衡的阴阳。
Front Endocrinol (Lausanne). 2021 Nov 22;12:735515. doi: 10.3389/fendo.2021.735515. eCollection 2021.

本文引用的文献

1
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.孤儿受体配体人尾加压素II:在人体组织中的受体定位以及与内皮素-1血管收缩反应的比较
Br J Pharmacol. 2000 Oct;131(3):441-6. doi: 10.1038/sj.bjp.0703601.
2
Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues.大鼠B78/apj(人类APJ受体的同源物)编码mRNA及其内源性配体apelin在脑和外周组织中的分布。
Biochim Biophys Acta. 2000 Jun 21;1492(1):72-80. doi: 10.1016/s0167-4781(00)00072-5.
3
Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin.APJ的分子与功能特性。mRNA的组织分布及其与内源性配体apelin的相互作用。
J Biol Chem. 2000 Jul 14;275(28):21061-7. doi: 10.1074/jbc.M908417199.
4
Characterization of apelin, the ligand for the APJ receptor.APJ受体配体apelin的特性研究。
J Neurochem. 2000 Jan;74(1):34-41. doi: 10.1046/j.1471-4159.2000.0740034.x.
5
Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.一种新型人APJ受体内源性肽配体的分离与鉴定。
Biochem Biophys Res Commun. 1998 Oct 20;251(2):471-6. doi: 10.1006/bbrc.1998.9489.
6
Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.在衰竭的人类心室心肌中血管紧张素II 1型受体亚型的选择性下调。
Circulation. 1997 Mar 4;95(5):1193-200. doi: 10.1161/01.cir.95.5.1193.
7
Differential distribution of endothelin peptides and receptors in human adrenal gland.内皮素肽及受体在人肾上腺中的差异分布。
Histochem J. 1996 Nov;28(11):779-89. doi: 10.1007/BF02272151.
8
A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.一个与编码血管紧张素受体的基因具有同源性的人类基因位于11号染色体上。
Gene. 1993 Dec 22;136(1-2):355-60. doi: 10.1016/0378-1119(93)90495-o.
9
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium.人房室传导系统和心肌中内皮素受体亚型的特征与定位
Circ Res. 1993 Mar;72(3):526-38. doi: 10.1161/01.res.72.3.526.
10
Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.人血管系统中平滑肌表达的内皮素ETA和ETB mRNA及受体:以ETA亚型为主。
Br J Pharmacol. 1995 Mar;114(6):1110-6. doi: 10.1111/j.1476-5381.1995.tb13322.x.